{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:58:26Z","timestamp":1790665106543,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,21]]},"DOI":"10.7759\/cureus.37932","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T14:34:29Z","timestamp":1682087669000},"source":"Crossref","is-referenced-by-count":11,"title":["Ductal Carcinoma in Situ: A Detailed Review of Current Practices"],"prefix":"10.7759","author":[{"given":"Dheer S","family":"Kalwaniya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhur","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Pawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.20.1546","article-title":"Detection of ductal carcinoma in situ in women undergoing screening mammography","volume":"94","author":"Ernster VL","year":"2002","unstructured":"Ernster VL, Ballard-Barbash R, Barlow WE, et al.. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002, 94:1546-54. 10.1093\/jnci\/94.20.1546","journal-title":"J Natl Cancer Inst"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90057-n","article-title":"Non-invasive ductal carcinoma of the breast: the relevance of histologic categorization","volume":"24","author":"Bellamy CO","year":"1993","unstructured":"Bellamy CO, McDonald C, Salter DM, et al.. Non-invasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol. 1993, 24:16-23. 10.1016\/0046-8177(93)90057-n","journal-title":"Hum Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.12.013","article-title":"The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast","volume":"40","author":"Barnes NL","year":"2014","unstructured":"Barnes NL, Dimopoulos N, Williams KE, Howe M, Bundred NJ. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2014, 40:249-54. 10.1016\/j.ejso.2013.12.013","journal-title":"Eur J Surg Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L","article-title":"Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways","volume":"187","author":"Buerger H","year":"1999","unstructured":"Buerger H, Otterbach F, Simon R, et al.. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol. 1999, 187:4-396. 10.1002\/(SICI)1096-9896(199903)187:4&lt;396::AID-PATH286&gt;3.0.CO;2-L","journal-title":"J Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B","article-title":"Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes","volume":"189","author":"Buerger H","year":"1999","unstructured":"Buerger H, Otterbach F, Simon R, et al.. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol. 1999, 189:4-521. 10.1002\/(SICI)1096-9896(199912)189:4&lt;521::AID-PATH472&gt;3.0.CO;2-B","journal-title":"J Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0675-8","article-title":"Gene amplification in ductal carcinoma in situ of the breast","volume":"123","author":"Burkhardt L","year":"2010","unstructured":"Burkhardt L, Grob TJ, Hermann I, et al.. Gene amplification in ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2010, 123:757-65. 10.1007\/s10549-009-0675-8","journal-title":"Breast Cancer Res Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.9.697","article-title":"Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci","volume":"90","author":"O'Connell P","year":"1998","unstructured":"O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst. 1998, 90:697-703. 10.1093\/jnci\/90.9.697","journal-title":"J Natl Cancer Inst"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir IL","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B, et al.. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011, 103:478-88. 10.1093\/jnci\/djr027","journal-title":"J Natl Cancer Inst"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2004.06.034","article-title":"Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast","volume":"188","author":"Romero L","year":"2004","unstructured":"Romero L, Klein L, Ye W, et al.. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg. 2004, 188:371-6. 10.1016\/j.amjsurg.2004.06.034","journal-title":"Am J Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod SA","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015, 1:888-96. 10.1001\/jamaoncol.2015.2510","journal-title":"JAMA Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh069","article-title":"Trends in the treatment of ductal carcinoma in situ of the breast","volume":"96","author":"Baxter NN","year":"2004","unstructured":"Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004, 96:443-8. 10.1093\/jnci\/djh069","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.1366","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group","volume":"24","author":"Bijker N","year":"2006","unstructured":"Bijker N, Meijnen P, Peterse JL, et al.. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006, 24:3381-7. 10.1200\/JCO.2006.06.1366","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgq035","article-title":"Ductal carcinoma in situ: terminology, classification, and natural history","volume":"2010","author":"Allred DC","year":"2010","unstructured":"Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010, 2010:134-8. 10.1093\/jncimonographs\/lgq035","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.7.596","article-title":"Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast","volume":"50","author":"Quinn CM","year":"1997","unstructured":"Quinn CM, Ostrowski JL. Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast. J Clin Pathol. 1997, 50:596-9. 10.1136\/jcp.50.7.596","journal-title":"J Clin Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(95)90982-6","article-title":"Prognostic classification of breast ductal carcinoma-in-situ","volume":"345","author":"Silverstein MJ","year":"1995","unstructured":"Silverstein MJ, Poller DN, Waisman JR, et al.. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995, 345:1154-1157. 10.1016\/s0140-6736(95)90982-6","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5858\/133.1.15","article-title":"Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast","volume":"133","author":"Lester SC","year":"2009","unstructured":"Lester SC, Bose S, Chen YY, et al.. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med. 2009, 133:15-25. 10.5858\/133.1.15","journal-title":"Arch Pathol Lab Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(03)00265-4","article-title":"The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast","volume":"186","author":"Silverstein MJ","year":"2003","unstructured":"Silverstein MJ. The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003, 186:337-343. 10.1016\/s0002-9610(03)00265-4","journal-title":"Am J Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer A","year":"2012","unstructured":"Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012, 367:1998-2005. 10.1056\/NEJMoa1206809","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1430-5","article-title":"Characterizing the impact of 25 years of DCIS treatment","volume":"129","author":"Ozanne EM","year":"2011","unstructured":"Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011, 129:165-73. 10.1007\/s10549-011-1430-5","journal-title":"Breast Cancer Res Treat"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-1262","article-title":"Incidence of ductal carcinoma in situ in the United States, 2000-2014","volume":"28","author":"Ryser MD","year":"2019","unstructured":"Ryser MD, Hendrix LH, Worni M, Liu Y, Hyslop T, Hwang ES. Incidence of ductal carcinoma in situ in the United States, 2000-2014. Cancer Epidemiol Biomarkers Prev. 2019, 28:1316-23. 10.1158\/1055-9965.EPI-18-1262","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.08.013","article-title":"Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network","volume":"50","author":"Lynge E","year":"2014","unstructured":"Lynge E, Ponti A, James T, et al.. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Eur J Cancer. 2014, 50:185-92. 10.1016\/j.ejca.2013.08.013","journal-title":"Eur J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26460","article-title":"Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer","volume":"131","author":"Reeves GK","year":"2012","unstructured":"Reeves GK, Pirie K, Green J, Bull D, Beral V. Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer. 2012, 131:930-7. 10.1002\/ijc.26460","journal-title":"Int J Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9375-9","article-title":"Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women","volume":"103","author":"Reinier KS","year":"2007","unstructured":"Reinier KS, Vacek PM, Geller BM. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women. Breast Cancer Res Treat. 2007, 103:343-8. 10.1007\/s10549-006-9375-9","journal-title":"Breast Cancer Res Treat"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.8.964","article-title":"Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ","volume":"293","author":"Claus EB","year":"2005","unstructured":"Claus EB, Petruzella S, Matloff E, Carter D. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA. 2005, 293:964-9. 10.1001\/jama.293.8.964","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-3-67","article-title":"Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study","volume":"3","author":"Saxena S","year":"2005","unstructured":"Saxena S, Rekhi B, Bansal A, Bagga A, Chintamani, Murthy NS. Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study. World J Surg Oncol. 2005, 3:67. 10.1186\/1477-7819-3-67","journal-title":"World J Surg Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.5.256","article-title":"Standard for the management of ductal carcinoma in situ of the breast (DCIS)","volume":"52","author":"Morrow M","year":"2002","unstructured":"Morrow M, Strom EA, Bassett LW, et al.. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002, 52:256-76. 10.3322\/canjclin.52.5.256","journal-title":"CA Cancer J Clin"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig BA","year":"2010","unstructured":"Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010, 102:170-8. 10.1093\/jnci\/djp482","journal-title":"J Natl Cancer Inst"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.182.1.1820101","article-title":"Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ","volume":"182","author":"Yang WT","year":"2004","unstructured":"Yang WT, Tse GM. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR Am J Roentgenol. 2004, 182:101-10. 10.2214\/ajr.182.1.1820101","journal-title":"AJR Am J Roentgenol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0147-0272(00)90013-8","article-title":"Part II. Medical imaging of ductal carcinoma in situ","volume":"24","author":"Wright B","year":"2000","unstructured":"Wright B, Shumak R. Part II. Medical imaging of ductal carcinoma in situ. Curr Probl Cancer. 2000, 24:112-124. 10.1016\/s0147-0272(00)90013-8","journal-title":"Curr Probl Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1148\/rg.305095073","article-title":"Radiologic-pathologic correlation of ductal carcinoma in situ","volume":"30","author":"Yamada T","year":"2010","unstructured":"Yamada T, Mori N, Watanabe M, Kimijima I, Okumoto T, Seiji K, Takahashi S. Radiologic-pathologic correlation of ductal carcinoma in situ. Radiographics. 2010, 30:1183-98. 10.1148\/rg.305095073","journal-title":"Radiographics"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.181.6.1811679","article-title":"Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass","volume":"181","author":"Stomper PC","year":"2003","unstructured":"Stomper PC, Geradts J, Edge SB, Levine EG. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol. 2003, 181:1679-84. 10.2214\/ajr.181.6.1811679","journal-title":"AJR Am J Roentgenol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2006.08.003","article-title":"Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention","volume":"16","author":"Farshid G","year":"2007","unstructured":"Farshid G, Downey P, Gill PG. Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention. Breast. 2007, 16:161-71. 10.1016\/j.breast.2006.08.003","journal-title":"Breast"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.11240","article-title":"Diagnostic accuracy and recall rates for digital mammography and digital mammography combined with one-view and two-view tomosynthesis: results of an enriched reader study","volume":"202","author":"Rafferty EA","year":"2014","unstructured":"Rafferty EA, Park JM, Philpotts LE, Poplack SP, Sumkin JH, Halpern EF, Niklason LT. Diagnostic accuracy and recall rates for digital mammography and digital mammography combined with one-view and two-view tomosynthesis: results of an enriched reader study. AJR Am J Roentgenol. 2014, 202:273-81. 10.2214\/AJR.13.11240","journal-title":"AJR Am J Roentgenol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12121373","article-title":"Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program","volume":"267","author":"Skaane P","year":"2013","unstructured":"Skaane P, Bandos AI, Gullien R, et al.. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013, 267:47-56. 10.1148\/radiol.12121373","journal-title":"Radiology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.4656","article-title":"Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison","volume":"196","author":"Spangler ML","year":"2011","unstructured":"Spangler ML, Zuley ML, Sumkin JH, et al.. Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison. AJR Am J Roentgenol. 2011, 196:320-4. 10.2214\/AJR.10.4656","journal-title":"AJR Am J Roentgenol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.18.2151","article-title":"Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer","volume":"299","author":"Berg WA","year":"2008","unstructured":"Berg WA, Blume JD, Cormack JB, et al.. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008, 299:2151-63. 10.1001\/jama.299.18.2151","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgq030","article-title":"Magnetic resonance imaging in the evaluation of ductal carcinoma in situ","volume":"2010","author":"Lehman CD","year":"2010","unstructured":"Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010, 2010:150-1. 10.1093\/jncimonographs\/lgq030","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61232-X","article-title":"MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study","volume":"370","author":"Kuhl CK","year":"2007","unstructured":"Kuhl CK, Schrading S, Bieling HB, et al.. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007, 370:485-492. 10.1016\/S0140-6736(07)61232-X","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/path.1691","article-title":"Molecular evolution of breast cancer","volume":"205","author":"Simpson PT","year":"2005","unstructured":"Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol. 2005, 205:248-54. 10.1002\/path.1691","journal-title":"J Pathol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62070-5","article-title":"Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial","volume":"375","author":"Turnbull L","year":"2010","unstructured":"Turnbull L, Brown S, Harvey I, et al.. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010, 375:563-571. 10.1016\/S0140-6736(09)62070-5","journal-title":"Lancet"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/bcr650","article-title":"The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions","volume":"5","author":"Reis-Filho JS","year":"2003","unstructured":"Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res. 2003, 5:313-9. 10.1186\/bcr650","journal-title":"Breast Cancer Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher B","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N, et al.. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999, 353:1993-2000. 10.1016\/S0140-6736(99)05036-9","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred DC","year":"2012","unstructured":"Allred DC, Anderson SJ, Paik S, et al.. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol. 2012, 30:1268-73. 10.1200\/JCO.2010.34.0141","journal-title":"J Clin Oncol"},{"key":"ref44","unstructured":"College of American Pathologist. College of American Pathologist protocols. (2022). Accessed: April 21, 2023: http:\/\/www.cap.org.."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1000-9","article-title":"Is there a role for MRI in the preoperative assessment of patients with DCIS?","volume":"17","author":"Allen LR","year":"2010","unstructured":"Allen LR, Lago-Toro CE, Hughes JH, et al.. Is there a role for MRI in the preoperative assessment of patients with DCIS?. Ann Surg Oncol. 2010, 17:2395-400. 10.1245\/s10434-010-1000-9","journal-title":"Ann Surg Oncol"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar WJ","year":"2022","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al.. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022, 20:691-722.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2005.06.005","article-title":"Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins","volume":"190","author":"MacDonald HR","year":"2005","unstructured":"MacDonald HR, Silverstein MJ, Mabry H, et al.. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005, 190:521-5. 10.1016\/j.amjsurg.2005.06.005","journal-title":"Am J Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.5182","article-title":"Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ","volume":"27","author":"Dunne C","year":"2009","unstructured":"Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009, 27:1615-20. 10.1200\/JCO.2008.17.5182","journal-title":"J Clin Oncol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.3573","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology-American Society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"34","author":"Morrow M","year":"2016","unstructured":"Morrow M, Van Zee KJ, Solin LJ, et al.. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. J Clin Oncol. 2016, 34:4040-6. 10.1200\/JCO.2016.68.3573","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher B","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al.. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 2005, 97:1652-62. 10.1093\/jnci\/dji372","journal-title":"J Natl Cancer Inst"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher B","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al.. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998, 90:1371-88. 10.1093\/jnci\/90.18.1371","journal-title":"J Natl Cancer Inst"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.4.302","article-title":"Effects of tamoxifen on benign breast disease in women at high risk for breast cancer","volume":"95","author":"Tan-Chiu E","year":"2003","unstructured":"Tan-Chiu E, Wang J, Costantino JP, et al.. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. J Natl Cancer Inst. 2003, 95:302-7. 10.1093\/jnci\/95.4.302","journal-title":"J Natl Cancer Inst"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG","year":"2005","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365:1687-1717. 10.1016\/S0140-6736(05)66544-0","journal-title":"Lancet"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01129-0","article-title":"Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial","volume":"387","author":"Forbes JF","year":"2016","unstructured":"Forbes JF, Sestak I, Howell A, et al.. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. Lancet. 2016, 387:866-73. 10.1016\/S0140-6736(15)01129-0","journal-title":"Lancet"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01168-X","article-title":"Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial","volume":"387","author":"Margolese RG","year":"2016","unstructured":"Margolese RG, Cecchini RS, Julian TB, et al.. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet. 2016, 387:849-56. 10.1016\/S0140-6736(15)01168-X","journal-title":"Lancet"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.8560","article-title":"Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group","volume":"27","author":"Hughes LL","year":"2009","unstructured":"Hughes LL, Wang M, Page DL, et al.. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009, 27:5319-24. 10.1200\/JCO.2009.21.8560","journal-title":"J Clin Oncol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology\/RTOG 9804","volume":"39","author":"McCormick B","year":"2021","unstructured":"McCormick B, Winter KA, Woodward W, et al.. Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology\/RTOG 9804. J Clin Oncol. 2021, 39:3574-82. 10.1200\/JCO.21.01083","journal-title":"J Clin Oncol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini FA","year":"2019","unstructured":"Vicini FA, Cecchini RS, White JR, et al.. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019, 394:2155-64. 10.1016\/S0140-6736(19)32514-0","journal-title":"Lancet"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan TJ","year":"2019","unstructured":"Whelan TJ, Julian JA, Berrang TS, et al.. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019, 394:2165-2172. 10.1016\/S0140-6736(19)32515-2","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi L","year":"2015","unstructured":"Livi L, Meattini I, Marrazzo L, et al.. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015, 51:451-63. 10.1016\/j.ejca.2014.12.013","journal-title":"Eur J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142043-ductal-carcinoma-in-situ-a-detailed-review-of-current-practices","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:54Z","timestamp":1707508794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142043-ductal-carcinoma-in-situ-a-detailed-review-of-current-practices"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.37932","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,21]]}}}